Interleukin-18-deficient mice develop dyslipidemia resulting in nonalcoholic fatty liver disease and steatohepatitis.
Yamanishi K, Maeda S, Kuwahara-Otani S, Watanabe Y, Yoshida M, Ikubo K, Okuzaki D, El-Darawish Y, Li W, Nakasho K, Nojima H, Yamanishi H, Hayakawa T, Okamura H, Matsunaga H.
Yamanishi K, et al. Among authors: okamura h.
Transl Res. 2016 Jul;173:101-114.e7. doi: 10.1016/j.trsl.2016.03.010. Epub 2016 Mar 19.
Transl Res. 2016.
PMID: 27063959